Trulieve Cannabis Corp. (TRLV) Stock Overview
Trulieve Cannabis Corp. (ticker TRLV) closed the most recent 24‑hour trading session at USD 11.00 per share, reflecting a 1.95 % increase to USD 11.00 as of 07:12 AM Central Europe on Thursday, 22 November 2026.
Key Market Data
| Item | Value |
|---|---|
| Current share price | USD 11.00 |
| Shares outstanding | 192.8 million |
| Market capitalization | USD 2.10 billion |
| 24‑hour trading volume | USD 16.6 million |
| Price change since last month‑end | –11.79 % |
| 200‑day simple moving average | USD 8.75 |
| 52‑week high | USD 13.28 (06 September 2026) |
| 52‑week low | USD 4.62 (19 November 2025) |
Trulieve’s stock is listed on the Other‑OTC stock exchange. The company is headquartered in Quincy, United States, and operates as a health‑care holding company. Its subsidiaries are engaged in cultivation, possession, sale, and distribution of medical cannabis products designed to alleviate symptoms associated with serious medical conditions such as cancer. For more information, visit the company website at www.trulieve.com .
Recent Performance of Peer Companies
The following table summarizes the performance of several related stocks during the last 24 hours:
| Company | Ticker | 24‑hour change | Current price | Market cap | P/E ratio (or P/earnings) |
|---|---|---|---|---|---|
| Gabelli & Income Trust | GDV‑PK | –0.26 % | USD 16.55 | USD 2.5 billion | 5.19 |
| Kohl’s Corporation | KSS | +1.93 % | USD 22.16 | USD 2.5 billion | 9.26 |
| First Busey Corp. | BUSE | –0.43 % | USD 29.77 | USD 2.5 billion | 12.46 |
| Lincoln Financial Group | LCLN | –0.58 % | USD 24.00 | USD 2.5 billion | 5.83 |
| Precigen Inc. | PGEN | –3.37 % | USD 6.60 | USD 2.5 billion | – |
These figures provide context for investors assessing Trulieve’s recent performance relative to its peers in the broader market.
